1 / 10

Testing, Piloting and Evaluating RiskMAP Interventions

In this presentation by Annette Stemhagen, DrPH, FISPE, Vice President of Strategic Development Services, learn how to determine the potential success of your intervention approach through thorough feasibility assessments and ongoing evaluations. Explore the importance of stakeholder engagement, program design fit, and the use of existing data, including medical records and market research. Understand how to collect and analyze both qualitative and quantitative data to make informed decisions, ensuring your program can adapt and succeed from initiation to full implementation.

rumor
Télécharger la présentation

Testing, Piloting and Evaluating RiskMAP Interventions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Testing, Piloting and Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President, Strategic Development Services

  2. How Can You Determine if Your Approach Will Succeed? • Feasibility assessments prior to program initiation • Ongoing evaluation over the life of the program

  3. Initial Feasibility Assessments • The likelihood of success with • Stakeholders • Physicians • Pharmacists • Patients • Others • Program Design • Fit busy practice routine • Represent actual clinical practice • Need for extra-ordinary testing

  4. Assessing Feasibility • Existing data • Medical chart review • Natural history of disease • Cross sectional surveys, e.g., NCHS • Registries • Large automated databases

  5. Assessing Feasibility • Existing data (continued) • Market research data • Competitive products • Physician prescribing behavior • ISS and ISE (particularly placebo groups) • Literature • Past experience

  6. Assessing Feasibility • Ad hoc data collection • Panel of experts • Focus groups • Surveys • Health care providers • Patients • General population sample

  7. Ongoing Feasibility • How good were the data? • How good were the assumptions?

  8. Ongoing Feasibility • Projected vs. actual • Corrections mid-course

  9. Test Risk Intervention Prior to Full Implementation • Traditional clinical trials • LSTs • Demonstration programs

  10. Evaluation Strategies • Record review • Stakeholder Surveys • Knowledge, Attitude and Practice • Program audits • System audit trail • Large automated database study • Market research data

More Related